EMEA (Europe, Middle East and Africa) Influenza Vaccine Market Report 2017

October 2017 | 118 pages | ID: E89727A1DE1EN
QYResearch

Abstracts

In this report, the EMEA Influenza Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Influenza Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Influenza Vaccine market competition by top manufacturers/players, with Influenza Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Sinovac
• Changsheng
• CCBIO
• Aleph Biomedical
• Sanofi
• Lanzhou Institute Of Biological Product
• Siobp
• Hualan Bio
• Tianyuan Bio-Pharma
• Vaxtec
• Hissen
• Abbott
• Novartis
• Tasly&Jenner
• Tiantan

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Influenza Vaccine for each application, including

• Children
• Adults
• Elderly
• Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Influenza Vaccine Market Report 2017

1 INFLUENZA VACCINE OVERVIEW

1.1 Product Overview and Scope of Influenza Vaccine
1.2 Classification of Influenza Vaccine
  1.2.1 EMEA Influenza Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Influenza Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Trivalent Influenza Vaccine
  1.2.4 Quadrivalent Influenza Vaccine
  1.2.5 Other
1.3 EMEA Influenza Vaccine Market by Application/End Users
  1.3.1 EMEA Influenza Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children
  1.3.3 Adults
  1.3.4 Elderly
  1.3.5 Pregnancy
1.4 EMEA Influenza Vaccine Market by Region
  1.4.1 EMEA Influenza Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Influenza Vaccine (2012-2022)
  1.5.1 EMEA Influenza Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Influenza Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA INFLUENZA VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Influenza Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Influenza Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Influenza Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Influenza Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Influenza Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Influenza Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Influenza Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Influenza Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Influenza Vaccine (Volume) by Application
2.4 EMEA Influenza Vaccine (Volume and Value) by Region
  2.4.1 EMEA Influenza Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Influenza Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Influenza Vaccine Sales Price by Region (2012-2017)

3 EUROPE INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Influenza Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Influenza Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Influenza Vaccine Sales and Market Share by Type
3.3 Europe Influenza Vaccine Sales and Market Share by Application
3.4 Europe Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Influenza Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Influenza Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Influenza Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Influenza Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Influenza Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Influenza Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Influenza Vaccine Sales and Market Share by Type
4.3 Middle East Influenza Vaccine Sales and Market Share by Application
4.4 Middle East Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Influenza Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Influenza Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Influenza Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Influenza Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA INFLUENZA VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Influenza Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Influenza Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Influenza Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Influenza Vaccine Sales and Market Share by Type
5.3 Africa Influenza Vaccine Sales and Market Share by Application
5.4 Africa Influenza Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Influenza Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Influenza Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Influenza Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Influenza Vaccine Sales and Growth Rate (2012-2017)

6 EMEA INFLUENZA VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Influenza Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sinovac
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Influenza Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Changsheng
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Influenza Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Changsheng Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CCBIO
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Influenza Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CCBIO Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aleph Biomedical
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Influenza Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aleph Biomedical Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Influenza Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lanzhou Institute Of Biological Product
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Influenza Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lanzhou Institute Of Biological Product Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Siobp
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Influenza Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siobp Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Hualan Bio
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Influenza Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Tianyuan Bio-Pharma
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Influenza Vaccine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Tianyuan Bio-Pharma Influenza Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Vaxtec
6.12 Hissen
6.13 Abbott
6.14 Novartis
6.15 Tasly&Jenner
6.16 Tiantan

7 INFLUENZA VACCINE MANUFACTURING COST ANALYSIS

7.1 Influenza Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Influenza Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INFLUENZA VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Influenza Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Influenza Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Influenza Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Influenza Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Influenza Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Influenza Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Influenza Vaccine
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Influenza Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure EMEA Influenza Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Influenza Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Influenza Vaccine Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Players (2012-2017)
Figure 2016 Influenza Vaccine Sales Share by Players
Figure 2017 Influenza Vaccine Sales Share by Players
Figure EMEA Influenza Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Influenza Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Influenza Vaccine Revenue Share by Players
Table 2017 EMEA Influenza Vaccine Revenue Share by Players
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Type (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Type in 2016
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Application (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share by Application in 2016
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Influenza Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Influenza Vaccine by Region (2012-2017)
Figure EMEA Influenza Vaccine Sales Market Share in 2016
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Influenza Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Influenza Vaccine by Region (2012-2017)
Figure EMEA Influenza Vaccine Revenue Market Share Regions in 2016
Table EMEA Influenza Vaccine Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Influenza Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Europe Influenza Vaccine Market Share by Type (2012-2017)
Figure Europe Influenza Vaccine Market Share by Type in 2016
Table Europe Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Europe Influenza Vaccine Market Share by Application (2012-2017)
Figure Europe Influenza Vaccine Market Share by Application in 2016
Table Europe Influenza Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Sales Market Share by Countries in 2016
Table Europe Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Germany Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Influenza Vaccine Market Share by Type (2012-2017)
Figure Middle East Influenza Vaccine Market Share by Type (2012-2017)
Table Middle East Influenza Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Influenza Vaccine Market Share by Applications (2012-2017)
Figure Middle East Influenza Vaccine Sales Market Share by Application in 2016
Table Middle East Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Influenza Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Influenza Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Type in 2016
Table Africa Influenza Vaccine Sales (K Doses) by Application (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Application (2012-2017)
Table Africa Influenza Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Sales Market Share by Countries in 2016
Table Africa Influenza Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table GSK Influenza Vaccine Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure GSK Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sinovac Influenza Vaccine Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sinovac Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sinovac Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sinovac Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changsheng Influenza Vaccine Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changsheng Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Changsheng Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changsheng Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table CCBIO Influenza Vaccine Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CCBIO Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure CCBIO Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure CCBIO Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Aleph Biomedical Influenza Vaccine Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sanofi Influenza Vaccine Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Sanofi Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Lanzhou Institute Of Biological Product Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Siobp Influenza Vaccine Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Siobp Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Siobp Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Siobp Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Hualan Bio Influenza Vaccine Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Hualan Bio Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Hualan Bio Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Tianyuan Bio-Pharma Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share in EMEA (2012-2017)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share in EMEA (2012-2017)
Table Vaxtec Influenza Vaccine Basic Information List
Table Hissen Influenza Vaccine Basic Information List
Table Abbott Influenza Vaccine Basic Information List
Table Novartis Influenza Vaccine Basic Information List
Table Tasly&Jenner Influenza Vaccine Basic Information List
Table Tiantan Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2016
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure EMEA Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Vaccine Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Influenza Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Influenza Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Influenza Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Influenza Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources